- Home
- GPOR vs VCYT Comparison
GPOR vs VCYT Comparison
Compare GPOR & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GPOR | VCYT |
|---|---|---|
| Founded | 1997 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical Specialities |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 3.2B |
| IPO Year | 1998 | 2013 |
Fundamental Metrics
Financial Performance| Metric | GPOR | VCYT |
|---|---|---|
| Price | $160.62 | $44.58 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 13 |
| Target Price | ★ $214.85 | $58.42 |
| AVG Volume (30 Days) | 248.1K | ★ 1.3M |
| Earning Date | 11-03-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 245.92 | 164.52 |
| EPS | ★ 13.82 | 0.66 |
| Revenue | ★ $1,422,583,000.00 | N/A |
| Revenue This Year | $16.26 | $14.80 |
| Revenue Next Year | $1.94 | $11.21 |
| P/E Ratio | ★ $11.44 | $72.19 |
| Revenue Growth | ★ 48.47 | N/A |
| 52 Week Low | $149.18 | $29.46 |
| 52 Week High | $225.78 | $60.91 |
Technical Indicators
Market Signals| Indicator | GPOR | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 47.36 | 50.34 |
| Support Level | $158.91 | $40.03 |
| Resistance Level | $162.64 | $46.10 |
| Average True Range (ATR) | 4.68 | 2.79 |
| MACD | -0.36 | 0.50 |
| Stochastic Oscillator | 44.99 | 58.34 |
Price Performance
Historical ComparisonAbout GPOR Gulfport Energy Corporation
Gulfport Energy Corp is an independent natural gas-weighted exploration and production company focused on the exploration, acquisition, and production of natural gas, crude oil, and natural gas liquids, with assets located in the Appalachia and Anadarko basins in the United States. The principal properties of the company are located in eastern Ohio, targeting the Utica and Marcellus, and in central Oklahoma, targeting the SCOOP Woodford and Springer formations.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).